The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease

Overview of attention for article published in Science Translational Medicine, October 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 6 news outlets
blogs: 2 blogs
twitter: 17 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 85 Mendeley

So far, Altmetric has seen 17 X posts from 17 X users, with an upper bound of 923,976 followers.

Vasotide, a peptidomimetic that inhibits VEGF-related retinal angiogenesis: https://t.co/zJn6U4qiUv

The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis @Harvard https://t.co/jtdcKnzNwP

Pesquisador do Instituto de Química da USP publica artigo na revista Science Translational Medicine de outubro de... https://t.co/cTfFITa5en

Vasotide targets VEGF receptors and reduces pathological angiogenesis in models of retinal disease https://t.co/xbXGPMgyvt

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.